Coloplast A/S (CPH:COLO.B)
Denmark · Delayed Price · Currency is DKK 587.60
-9.00 (-1.51%)
Sep 17, 2025, 4:59 PM CET
Coloplast Market Cap
Coloplast has a market cap or net worth of 134.33 billion as of September 17, 2025. Its market cap has decreased by -35.02% in one year.
Market Cap
134.33B
Enterprise Value
157.82B
Revenue
27.87B
Ranking
n/a
PE Ratio
33.01
Stock Price
587.60
Market Cap Chart
Since November 17, 1997, Coloplast's market cap has increased from 5.88B to 134.33B, an increase of 2,184.60%. That is a compound annual growth rate of 11.89%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Sep 16, 2025 | 134.33B | -24.11% |
| Dec 30, 2024 | 177.00B | 2.05% |
| Dec 29, 2023 | 173.44B | 0.54% |
| Dec 30, 2022 | 172.51B | -29.57% |
| Dec 30, 2021 | 244.93B | 23.89% |
| Dec 30, 2020 | 197.71B | 12.62% |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Novo Nordisk | 1,595.64B |
| Genmab | 109.23B |
| Demant | 50.91B |
| ALK-Abelló | 45.79B |
| H. Lundbeck | 41.24B |
| Zealand Pharma | 30.08B |
| Ambu A/S | 26.27B |
| Bavarian Nordic | 18.14B |